RICHARD WHITEHEAD: Open Payments
NPI 1487630919 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,671 in 113 payments from 19 companies in 2025. Trend: 2023 $2,350 · 2024 $2,086 · 2025 $2,671
Food & beverage: $2,671
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $364 |
| ABBVIE INC. | 21 | $350 |
| Madrigal Pharmaceuticals | 7 | $296 |
| Ardelyx, Inc. | 11 | $265 |
| Gilead Sciences, Inc. | 11 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $243 |
| Aimmune Therapeutics, Inc. | 7 | $210 |
| Janssen Biotech, Inc. | 10 | $195 |
| QOL Medical, LLC | 2 | $75 |
| Ethicon US, LLC | 1 | $73 |
Products named: XIFAXAN, REZDIFFRA, IBSRELA, ZENPEP, TREMFYA, ENTYVIO, SKYRIZI, MAVYRET.
Industry payments across CT — which companies pay providers there.
